Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kaska Kowanetz
Identification of Preferred Chemotherapeutics for Combining With a CHK1 Inhibitor
Molecular Cancer Therapeutics
Cancer Research
Oncology
Related publications
Tumour Growth Environment Modulates Chk1 Signalling Pathways and Chk1 Inhibitor Sensitivity
Scientific Reports
Multidisciplinary
γH2AX and Chk1 Phosphorylation as Predictive Pharmacodynamic Biomarkers of Chk1 Inhibitor-Chemotherapy Combination Treatments
BMC Cancer
Cancer Research
Oncology
Genetics
A Multivariable Model for Identification of Preferred Location of Wind Plants
Renewable Energy and Power Quality Journal
Electronic Engineering
Energy Engineering
Renewable Energy
Sustainability
Electrical
Power Technology
the Environment
Combining Ketamine With Astrocytic Inhibitor as a Potential Analgesic Strategy for Neuropathic Pain. Ketamine, Astrocytic Inhibitor and Pain
Molecular Pain
Molecular Medicine
Anesthesiology
Pain Medicine
Cellular
Molecular Neuroscience
Topotecan Synergizes With CHEK1 (CHK1) Inhibitor to Induce Apoptosis in Ovarian Cancer Cells
BMC Cancer
Cancer Research
Oncology
Genetics
MK-8776, a Novel Chk1 Kinase Inhibitor, Radiosensitizes P53-Defective Human Tumor Cells
Oncotarget
Oncology
Combining PCI-24781, a Novel Histone Deacetylase Inhibitor, With Chemotherapy for the Treatment of Soft Tissue Sarcoma
Clinical Cancer Research
Cancer Research
Oncology
Correction: Combining PCI-24781, a Novel Histone Deacetylase Inhibitor, With Chemotherapy for the Treatment of Soft Tissue Sarcoma
Clinical Cancer Research
Cancer Research
Oncology
Identification of CP77 as the Third Orthopoxvirus SAMD9 and SAMD9L Inhibitor With a Unique Specificity for a Rodent SAMD9L
Journal of Virology
Insect Science
Immunology
Microbiology
Virology
